Anxiety Disorders
📧 Sign up to get email alerts when something new happens for Anxiety Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Anesthetic Premedication With a Cannabis Extract (Cannapremed) [Phase 2, Phase 3]
Phase 2/3 trial update on Cannapremed, an anesthetic premedication using a cannabis extract, with conditions including postoperative pain, p…
-
FDA approval · 2024-02-12FDA Approved: LORAZEPAM — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for lorazepam from Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Augmenting Hospitalization for Serious Mental Illness: Cognitive Bias Modification [NA]
A completed clinical trial evaluating cognitive bias modification as an adjunctive treatment for serious mental illness. Results have been p…
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Expectation of Unpleasant Events in Anxiety Disorders [NA]
Clinical trial update on anxiety disorders with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: EaseVRx-8w+ for the Treatment of Chronic Lower Back Pain [NA]
Results for the EaseVRx-8w+ VR therapy trial in chronic low back pain (with associated anxiety and depression) have been posted; the study i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Opioid Treatment and Recovery Through a Safe Pain Management Program [NA]
ClinicalTrials.gov update shows the study 'Opioid Treatment and Recovery Through a Safe Pain Management Program' has completed and posted re…
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: Effectiveness of Energy Resonance by Skin Stimulation in the Management of Anxious Patients Who Require Scheduled Orthopaedic Surgery [Phase 3]
Phase 3 clinical trial evaluating Energy Resonance by Skin Stimulation for managing anxiety in patients undergoing scheduled orthopedic surg…
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: Treatment for Affect Dimensions [NA]
A UCLA-led clinical trial update reports completion of a treatment for affect dimensions in depressive disorders and anxiety disorders, with…
-
FDA approval · 2023-11-22FDA Approved: DIAZEPAM — Supplemental Application (Sunrise Pharmaceutical, Inc.)
The FDA approved a supplemental application for Diazepam submitted by Sunrise Pharmaceutical, Inc.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: CBD Oil for Reducing Emotional Impact of COVID-19 [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating CBD oil to reduce emotional impact related to COVID-19 is suspended.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Optimizing Mental Health in Orthopedic Care [NA]
A completed clinical trial (NCT05194722) sponsored by Washington University School of Medicine investigated optimizing mental health in orth…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Apply tACS to Alleviate Anxiety Symptoms [Phase 2]
Phase 2 clinical trial update investigating transcranial alternating current stimulation (tACS) to alleviate anxiety symptoms.
-
EMA withdrawal · 2023-10-12EMA Withdrawn: Pregabalin Sandoz GmbH (pregabalin) — Sandoz GmbH
The EMA withdrew the Pregabalin Sandoz GmbH (pregabalin) product from the market, affecting indications in Anxiety Disorders and Epilepsy.
-
FDA approval · 2023-10-11FDA Approved: VALIUM — Supplemental Application (Roche Laboratories Inc.)
FDA approved a Supplemental Application for Valium (diazepam) from Roche Laboratories Inc., indicating an approved change or addition to the…
-
FDA approval · 2023-09-25FDA Approved: LORAZEPAM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for lorazepam submitted by Hospira, Inc. under ANDA 074243.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Stepped-Care Telehealth for Distress in Cancer Survivors [NA]
Completed trial evaluating stepped-care telehealth for distress in cancer survivors, with outcomes including anxiety, depressive symptoms, s…
-
FDA approval · 2023-09-14FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic formulation of chlordiazepoxide hydrochloride and clidinium bromide from Aurobindo Pharma Limited under an Original A…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology
Clinical trial completed examining the impact of COVID-19 on psychopathology, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-28Clinical Trial Update: Transdiagnostic Cognitive Behavioral Treatment for Anxiety [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical trial update evaluating transdiagnostic cognitive behavioral treatment for anxiety disorders; study completed w…
-
CLINICAL_TRIALS research · 2023-08-23Clinical Trial Update: Parent Key Opinion Leaders to Increase Demand of Effective Treatments for Youth Anxiety [NA]
A completed clinical trial focusing on youth anxiety, communicated by Temple University, with results posted in 2023.
-
FDA approval · 2023-08-16FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved the original application for a generic doxepin hydrochloride product from Amneal Pharmaceuticals NY LLC. The generic is ind…
-
FDA approval · 2023-07-10FDA Approved: DIAZEPAM — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for Diazepam from Oceanside Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2023-07-05Clinical Trial Update: Substance Misuse To Psychiatric Disorders for Cannabis [Phase 2, Phase 3]
Phase 2/3 clinical trial update on a substance misuse to psychiatric disorders program focusing on cannabis use disorder with depressive/anx…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: A Pilot fMRI Study of TMS in Late-Life Severe Worry [NA]
A completed pilot fMRI study evaluating transcranial magnetic stimulation for late-life generalized anxiety disorder; results posted in 2023…
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Intranasal Dexmedetomidine Versus Intranasal Midazolam for MRI In Pediatrics [Phase 4]
Phase 4 trial comparing intranasal dexmedetomidine to intranasal midazolam for MRI in pediatric patients has completed.